Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Lancet Diabetes Endocrinol. 2017 Jun 11;5(8):597–609. doi: 10.1016/S2213-8587(17)30194-8

Figure 3.

Figure 3

Changes from baseline in secondary outcomes. Mean change from baseline for up to 3 years is shown for (A) HbA1c, (B) insulin dose requirement, (C) insulin dose requirement during first 6 months only, (D) LDL cholesterol, (E) bodyweight, and (F) estimated glomerular filtration rate (eGFR). Error bars show 95% CIs.